The National Society of Genetic Counselors (NSGC) recognizes that new and emerging gene-editing techniques may be a means to prevent, ameliorate, or cure genetic disease. As such, the concerns about risk, or unacceptable uses of gene-editing technologies, must be balanced against the benefits that they may bring to individuals and families affected by genetic diseases.

NSGC supports public funding for research that investigates the potential of germline editing in a manner that is regulated, transparent, and equitable. In addition, NSGC supports funding for research into the social and ethical implications of germline editing, including stakeholder and community engagement. Germline editing in human sperm, eggs, or embryos with the intention of creating a pregnancy should be considered only if and when safety and efficacy standards have been established and met. NSGC does not support human germline editing for clinical use at this time. (Adopted 2016, Reaffirmed 2020 and 2023)

Back to Position Statements